PMV Pharmaceuticals, Inc.
NASDAQ Global SelectTotal Valuation
PMV Pharmaceuticals, Inc. carries a market capitalization of 69.33M, placing it among publicly traded companies globally. Its enterprise value stands at -7.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 69.33M |
| Enterprise Value | -7.58M |
Share Statistics
PMV Pharmaceuticals, Inc. currently has 53.46M shares outstanding.
| Shares Outstanding | 53.46M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | -1.00 |
| P/OCF Ratio | -1.00 |
Financial Position
PMV Pharmaceuticals, Inc. maintains a current ratio of 7.70, meaning it holds 7.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.70 |
| Quick Ratio | 7.52 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -70.93 |
| Return on Assets (ROA) | -64.04 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 23,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
PMV Pharmaceuticals, Inc.'s stock has declined approximately -11.56463% over the past 52 weeks. The 50-day moving average sits at 1.38, while the 200-day moving average is 1.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.56463% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.30 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -79.54M, while operating income came in at -79.66M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -79.66M |
| Pretax Income | -75.20M |
| Net Income | -75.22M |
| EBITDA | -79.54M |
| EBIT | -79.66M |
| Earnings Per Share (EPS) | -1.41 |
Balance Sheet
PMV Pharmaceuticals, Inc. holds 79.43M in cash and equivalents against 217,000.00 in total debt, resulting in a net debt position of -12.47M. Total book value stands at 71.50M, with working capital of 70.84M providing operational flexibility.
| Cash & Cash Equivalents | 79.43M |
| Total Debt | 217,000.00 |
| Net Debt | -12.47M |
| Equity (Book Value) | 71.50M |
| Book Value Per Share | 1.34 |
| Working Capital | 70.84M |
Cash Flow
PMV Pharmaceuticals, Inc. produced -71.26M in operating cash flow over the past twelve months. After subtracting -14,000.00 in capital expenditures, free cash flow totaled -71.28M - equivalent to -1.34 per share.
| Operating Cash Flow | -71.26M |
| Capital Expenditures | -14,000.00 |
| Free Cash Flow | -71.28M |
| FCF Per Share | -1.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.75 |
| FCF Yield | -99.88 |
Scores
PMV Pharmaceuticals, Inc. posts an Altman Z-Score of -6.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.33 |